JP2004527573A - 哺乳類の神経組織損傷の治療のための方法及び組成物 - Google Patents

哺乳類の神経組織損傷の治療のための方法及び組成物 Download PDF

Info

Publication number
JP2004527573A
JP2004527573A JP2002589024A JP2002589024A JP2004527573A JP 2004527573 A JP2004527573 A JP 2004527573A JP 2002589024 A JP2002589024 A JP 2002589024A JP 2002589024 A JP2002589024 A JP 2002589024A JP 2004527573 A JP2004527573 A JP 2004527573A
Authority
JP
Japan
Prior art keywords
glycol
biomembrane
spinal cord
composition
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002589024A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004527573A5 (enExample
Inventor
シ，リイ
ビー． ボーゲンズ，リチャード
シー． リー，ラファエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Chicago
Original Assignee
University of Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Chicago filed Critical University of Chicago
Publication of JP2004527573A publication Critical patent/JP2004527573A/ja
Publication of JP2004527573A5 publication Critical patent/JP2004527573A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
JP2002589024A 2001-04-24 2002-04-24 哺乳類の神経組織損傷の治療のための方法及び組成物 Pending JP2004527573A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28620001P 2001-04-24 2001-04-24
PCT/US2002/013375 WO2002092107A1 (en) 2001-04-24 2002-04-24 Method and compositions for treating mammalian nerve tissue injuries

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009039488A Division JP2009112835A (ja) 2001-04-24 2009-02-23 哺乳類の神経組織損傷の治療のための方法及び組成物

Publications (2)

Publication Number Publication Date
JP2004527573A true JP2004527573A (ja) 2004-09-09
JP2004527573A5 JP2004527573A5 (enExample) 2005-12-22

Family

ID=23097525

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002589024A Pending JP2004527573A (ja) 2001-04-24 2002-04-24 哺乳類の神経組織損傷の治療のための方法及び組成物
JP2009039488A Pending JP2009112835A (ja) 2001-04-24 2009-02-23 哺乳類の神経組織損傷の治療のための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009039488A Pending JP2009112835A (ja) 2001-04-24 2009-02-23 哺乳類の神経組織損傷の治療のための方法及び組成物

Country Status (9)

Country Link
US (4) US7837987B2 (enExample)
EP (1) EP1389121B1 (enExample)
JP (2) JP2004527573A (enExample)
AT (1) ATE546146T1 (enExample)
AU (2) AU2002314758B2 (enExample)
CA (2) CA2740056A1 (enExample)
ES (1) ES2382899T3 (enExample)
NZ (2) NZ529526A (enExample)
WO (1) WO2002092107A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008542381A (ja) * 2005-05-31 2008-11-27 ウォーソー・オーソペディック・インコーポレーテッド 疼痛を治療するための組成物および方法
JP2009535416A (ja) * 2006-05-03 2009-10-01 ウォーソー・オーソペディック・インコーポレーテッド 神経損傷の処置のためのバイオメンブレンシーリング剤を含む組成物、および使用の方法

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582680B1 (en) 1998-11-12 2009-09-01 Purdue Research Foundation Methods and compositions for treating mammalian spinal cord injuries
US7442370B2 (en) 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US7276580B2 (en) * 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
AU2002314758B2 (en) 2001-04-24 2006-06-01 Purdue Research Foundation Method and composition for treating mammalian nerve tissue injuries
US7147647B2 (en) 2002-04-26 2006-12-12 Medtronic, Inc. Sintered titanium tube for the management of spinal cord injury
JP4571776B2 (ja) * 2002-11-05 2010-10-27 Ｊｘ日鉱日石エネルギー株式会社 潤滑油組成物
JP4742030B2 (ja) 2003-04-18 2011-08-10 バイオジェン・アイデック・エムエイ・インコーポレイテッド ポリマーが結合したグリコシル化ニューブラスチン
PT1786454E (pt) * 2004-08-19 2010-08-18 Biogen Idec Inc Variantes de neublastina
CN101123978B (zh) * 2004-08-19 2012-12-12 比奥根艾迪克Ma公司 神经胚素变体
US20060121016A1 (en) * 2004-10-18 2006-06-08 Lee Raphael C Methods and compositions for treatment of free radical injury
ATE432322T1 (de) * 2004-12-21 2009-06-15 Lubrizol Ltd Zusammensetzungen
US20070048731A1 (en) * 2005-05-20 2007-03-01 Neurosilicon High throughput use-dependent assay based on stimulation of cells on a silicon surface
US20070017530A1 (en) * 2005-06-10 2007-01-25 Syed Naweed I Detecting electrical activity and assessing agents for the ability to influence electrical activity
WO2006133555A1 (en) * 2005-06-15 2006-12-21 Neurosilicon (1145990 Alberta Ltd.) Psychotropic drug screening device based on long-term photoconductive stimulation of neurons
US20060287660A1 (en) * 2005-06-15 2006-12-21 Syed Naweed I Electrically Stimulating Nerve Regeneration
JP4907908B2 (ja) * 2005-06-29 2012-04-04 ルネサスエレクトロニクス株式会社 駆動回路及び表示装置
US20070092958A1 (en) * 2005-07-15 2007-04-26 Syed Naweed I Method and apparatus for guiding growth of neurons
US20070213718A1 (en) * 2006-02-14 2007-09-13 Sdgi Holdings, Inc. Treatment of the vertebral column
US20070213717A1 (en) * 2006-02-14 2007-09-13 Sdgi Holdings, Inc. Biological fusion in the vertebral column
US20070227547A1 (en) * 2006-02-14 2007-10-04 Sdgi Holdings, Inc. Treatment of the vertebral column
US20070213822A1 (en) * 2006-02-14 2007-09-13 Sdgi Holdings, Inc. Treatment of the vertebral column
TWI501774B (zh) * 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
US20100056440A1 (en) * 2006-03-01 2010-03-04 Biogen Idec Ma Inc. Compositions and methods for administering gdnf ligand family proteins
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US9675696B2 (en) * 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
TWI445544B (zh) 2007-05-01 2014-07-21 Biogen Idec Inc 增進血管形成之組合物及方法
US20110135648A1 (en) * 2007-08-08 2011-06-09 Biogen Idec Ma Inc. Anti-neublastin antibodies and uses thereof
US20090263507A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use
EP2350274B1 (en) 2008-10-21 2019-01-23 The General Hospital Corporation Cell transplantation
US8858924B2 (en) 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
US9078808B2 (en) 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation
US9244060B2 (en) * 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
CN102438657A (zh) 2009-03-26 2012-05-02 沃萨乌整形外科公司 鉴别定向药物递送组合物的潜在组分的方法
US8606371B2 (en) 2009-04-07 2013-12-10 Dignity Health Uterine electrical stimulation system and method
US20110230785A1 (en) * 2010-03-16 2011-09-22 ProNerve, LLC Somatosensory Evoked Potential (SSEP) Automated Alert System
JP6072684B2 (ja) 2010-08-06 2017-02-01 ザ ジェネラル ホスピタル コーポレーション ディー／ビー／エイ マサチューセッツ ジェネラル ホスピタル 細胞処置システムおよび細胞処置装置
WO2012058289A2 (en) 2010-10-27 2012-05-03 Dignity Health Uterine electrical stimulation system and method
US9872983B2 (en) 2010-10-27 2018-01-23 Dignity Health Uterine electrical stimulation system and method
WO2012161823A1 (en) * 2011-02-25 2012-11-29 The General Hospital Corporation D/B/A Massachusetts General Hospital Nerve coaptation apparatus
US20150127017A1 (en) * 2012-05-18 2015-05-07 Robert E. Garfield Electrical stimulation of the cervix
WO2014124142A2 (en) * 2013-02-07 2014-08-14 The Cleveland Clinic Foundation Methods of treating spinal cord injury
US10361003B2 (en) 2014-04-28 2019-07-23 Yeda Research And Development Co. Ltd. Method and apparatus for predicting response to food
GB2536650A (en) 2015-03-24 2016-09-28 Augmedics Ltd Method and system for combining video-based and optic-based augmented reality in a near eye display
ES2984412T3 (es) 2017-07-26 2024-10-29 Neuraptive Therapeutics Inc Dispositivo para administrar agentes terapéuticos a un nervio
US12458411B2 (en) 2017-12-07 2025-11-04 Augmedics Ltd. Spinous process clamp
WO2019211741A1 (en) 2018-05-02 2019-11-07 Augmedics Ltd. Registration of a fiducial marker for an augmented reality system
US11766296B2 (en) 2018-11-26 2023-09-26 Augmedics Ltd. Tracking system for image-guided surgery
US12178666B2 (en) 2019-07-29 2024-12-31 Augmedics Ltd. Fiducial marker
US11980506B2 (en) 2019-07-29 2024-05-14 Augmedics Ltd. Fiducial marker
JP7653164B2 (ja) * 2019-09-27 2025-03-28 バージニア コモンウェルス ユニバーシティー 組織を修復または増加させるための組成物および方法
US11382712B2 (en) 2019-12-22 2022-07-12 Augmedics Ltd. Mirroring in image guided surgery
JP2023511135A (ja) * 2020-01-21 2023-03-16 ザ・ペン・ステイト・リサーチ・ファウンデイション 神経損傷の治療及び／または創傷治癒の促進のための方法及び材料
US11389252B2 (en) 2020-06-15 2022-07-19 Augmedics Ltd. Rotating marker for image guided surgery
US20230190676A1 (en) * 2020-07-09 2023-06-22 Musc Foundation For Research Development Methods of protecting cells from insults
US12239385B2 (en) 2020-09-09 2025-03-04 Augmedics Ltd. Universal tool adapter
US11896445B2 (en) 2021-07-07 2024-02-13 Augmedics Ltd. Iliac pin and adapter
US12150821B2 (en) 2021-07-29 2024-11-26 Augmedics Ltd. Rotating marker and adapter for image-guided surgery
EP4388734A4 (en) 2021-08-18 2025-05-07 Augmedics Ltd. Stereoscopic display and digital magnifier for close-up augmented reality viewing
WO2023203521A1 (en) 2022-04-21 2023-10-26 Augmedics Ltd. Systems and methods for medical image visualization
US12268677B2 (en) 2022-04-27 2025-04-08 The Penn State Research Foundation 4-aminopyridine (4-AP) and bone morphogenetic protein 2 (BMP-2)
IL319523A (en) 2022-09-13 2025-05-01 Augmedics Ltd Augmented reality glasses for image-guided medical intervention

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369769A (en) 1980-06-13 1983-01-25 Edwards Charles C Spinal fixation device and method
US4599354A (en) 1985-03-11 1986-07-08 Morton Shulman Composition and method for producing prolonged pain relief
US6858409B1 (en) * 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US4919140A (en) 1988-10-14 1990-04-24 Purdue Research Foundation Method and apparatus for regenerating nerves
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
NL9000634A (nl) * 1990-03-20 1991-10-16 Catharina Ziekenhuis Stichting Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
EP0522134A1 (en) * 1991-01-11 1993-01-13 COBE Laboratories, Inc. Method of detecting circulating antibody types using dried or lyophilized cells or cell-like material
DE69230372T2 (de) 1991-03-19 2000-06-15 Cytrx Corp., Norcross Polyoxypropylen/polyoxyethylen copolymere mit verbesserter biologischer aktivität
US5470568A (en) 1992-02-13 1995-11-28 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for cell repair
US5324322A (en) * 1992-04-20 1994-06-28 Case Western Reserve University Thin film implantable electrode and method of manufacture
US5605687A (en) * 1992-05-15 1997-02-25 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for repair of electrical injury
EP0582164B1 (en) 1992-07-31 1998-12-23 Bristol-Myers Squibb Company Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles
CA2085785C (en) 1992-12-18 2005-03-15 Robert R. Hansebout The use of 4-aminopyridine in the treatment of a neurological condition
CN1103698C (zh) * 1995-02-14 2003-03-26 东丽株式会社 平版印刷版及平板印刷版原版
JPH09315972A (ja) 1996-03-22 1997-12-09 Chugai Pharmaceut Co Ltd 脊髄損傷治療剤
CA2284142C (en) 1997-03-19 2008-02-26 Lxr Biotechnology Inc. Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6440455B1 (en) 1997-09-02 2002-08-27 Children's Medical Center Corporation Methods for modulating the axonal outgrowth of central nervous system neurons
US7582680B1 (en) * 1998-11-12 2009-09-01 Purdue Research Foundation Methods and compositions for treating mammalian spinal cord injuries
US6232297B1 (en) * 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US6432434B1 (en) * 1999-04-22 2002-08-13 The United States Of America As Represented By The Secretary Of The Army Treatment of and/or prophylaxis against brain and spinal cord injury
AU2002314758B2 (en) * 2001-04-24 2006-06-01 Purdue Research Foundation Method and composition for treating mammalian nerve tissue injuries
AU2003300012A1 (en) 2002-12-30 2004-07-29 Indiana University Research & Technology Corporation Method of treatment for central nervous system injury

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008542381A (ja) * 2005-05-31 2008-11-27 ウォーソー・オーソペディック・インコーポレーテッド 疼痛を治療するための組成物および方法
JP2012211151A (ja) * 2005-05-31 2012-11-01 Warsaw Orthopaedic Inc 疼痛を治療するための組成物および方法
JP2009535416A (ja) * 2006-05-03 2009-10-01 ウォーソー・オーソペディック・インコーポレーテッド 神経損傷の処置のためのバイオメンブレンシーリング剤を含む組成物、および使用の方法
JP2014074061A (ja) * 2006-05-03 2014-04-24 Warsaw Orthopaedic Inc 神経損傷の処置のためのバイオメンブレンシーリング剤を含む組成物、および使用の方法

Also Published As

Publication number Publication date
US9687502B2 (en) 2017-06-27
US8460646B2 (en) 2013-06-11
AU2006200866A1 (en) 2006-03-23
CA2445612A1 (en) 2002-11-21
NZ529526A (en) 2006-06-30
CA2445612C (en) 2011-10-25
JP2009112835A (ja) 2009-05-28
EP1389121A4 (en) 2006-11-02
ATE546146T1 (de) 2012-03-15
US7837987B2 (en) 2010-11-23
US20030118545A1 (en) 2003-06-26
US20140100289A1 (en) 2014-04-10
EP1389121A1 (en) 2004-02-18
US9101655B2 (en) 2015-08-11
NZ543953A (en) 2007-04-27
CA2740056A1 (en) 2002-11-21
US20100016444A1 (en) 2010-01-21
ES2382899T3 (es) 2012-06-14
EP1389121B1 (en) 2012-02-22
AU2002314758B2 (en) 2006-06-01
WO2002092107A1 (en) 2002-11-21
AU2006200866B2 (en) 2007-11-08
US20050069520A1 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
JP2004527573A (ja) 哺乳類の神経組織損傷の治療のための方法及び組成物
AU2002314758A1 (en) Method and composition for treating mammalian nerve tissue injuries
Somjen Mechanisms of spreading depression and hypoxic spreading depression-like depolarization
BLIGHT et al. The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial
Borgens et al. Rapid recovery from spinal cord injury after subcutaneously administered polyethylene glycol
Donaldson et al. Polyethylene glycol rapidly restores physiological functions in damaged sciatic nerves of guinea pigs
Shi et al. Functional reconnection of severed mammalian spinal cord axons with polyethylene glycol
JP2006517807A (ja) 中枢神経系の損傷の治療方法
Borgens Cellular engineering: molecular repair of membranes to rescue cells of the damaged nervous system
Chen et al. Pushing the science forward: chitosan nanoparticles and functional repair of CNS tissue after spinal cord injury
Manto et al. (4-Aminopyridine)–PLGA–PEG as a Novel Thermosensitive and Locally Injectable Treatment for Acute Peripheral Nerve Injury
EP0626848A1 (en) The use of 4-aminopyridine in the treatment of a neurological condition
US7582680B1 (en) Methods and compositions for treating mammalian spinal cord injuries
Petrov et al. Neurorrhaphy in presence of polyethylene glycol enables immediate electrophysiological conduction in porcine model of facial nerve injury
KR20150117890A (ko) 척수 손상 동물모델 제조방법 및 이를 통해 제조된 척수 손상 동물모델
Engel Ultrastructural reactions in muscle disease
Añor Monoparesis
JP2023511135A (ja) 神経損傷の治療及び／または創傷治癒の促進のための方法及び材料
CN117143351B (zh) 用于治疗脊髓损伤的Zn-MOF及其制备方法和应用
Seitz et al. Toxic effects of triethyldodecylammoniumbromide (TEA-C12) on myelinated nerve fibers and blood-nerve barrier in the mouse
Zhou Polyethylene glycol (PEG) fusion repair of segmental-loss peripheral nerve injuries: outcomes, mechanisms, and clinical translation
WO2025049453A2 (en) Methods of treating musculoskeletal injuries
Borgens Recovery of Behavioral and Physiological Function In Vivo
US20220016125A1 (en) Riboflavin for treating collagenous tissues in the diseases of joints, particularly of invertebral discs
Satkeviciute Contribution of Axonal Transport Disruption to the Development of Neuropathic Pain

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050420

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050420

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080902

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081110

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090223

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090616